Perioperative Analgesia in a Dog with Chronic Kidney Disease
A 10-year-old male neutered Shetland Sheepdog (11 kg) is scheduled for dental extractions under general anesthesia. Labs: creatinine 3.1 mg/dL (reference 0.5–1.6), BUN 58 mg/dL, phosphorus 6.8 mg/dL (reference 2.5–6.0), urine specific gravity 1.012, PCV 34%, and total protein 6.0 g/dL. He is currently on benazepril 2.5 mg PO q24h for proteinuria and a renal diet. The owner reports he is 'a little stiff' in the mornings. The clinic stocks meloxicam, carprofen, buprenorphine, hydromorphone, gabapentin, tramadol, and fentanyl.
1. Evaluate the safety of NSAIDs for this dog's perioperative pain and explain the interaction with benazepril.
Read the worked answer
NSAIDs are contraindicated here. The creatinine of 3.1 mg/dL with a urine specific gravity of 1.012 indicates chronic kidney disease with impaired concentrating ability. NSAIDs reduce renal prostaglandin synthesis, which maintains afferent arteriolar dilation and renal blood flow-particularly important when renal perfusion is already compromised. Anesthesia adds hypotension and reduced renal perfusion, compounding the risk of acute-on-chronic kidney injury.
Interaction with benazepril. Benazepril is an ACE inhibitor that dilates the efferent arteriole, reducing intraglomerular pressure and slowing CKD progression. Combining an ACE inhibitor with an NSAID removes both compensatory mechanisms (afferent dilation from prostaglandins and efferent constriction from angiotensin II), producing a 'double hit' to glomerular filtration pressure. This combination is a well-recognized cause of acute kidney injury, especially in a volume-depleted or anesthetized patient. NSAIDs and ACE inhibitors should not be co-administered in a dog with CKD.
Practical guidance. Avoid meloxicam and carprofen entirely for this procedure. If chronic osteoarthritis pain needs management, consider gabapentin (which is renally cleared, so dose reduction is appropriate) and other non-NSAID modalities. Document the contraindication prominently.
2. Design an opioid-based perioperative analgesic plan, addressing the choice of agent, dose, and any renal considerations.
Read the worked answer
Premedication. Buprenorphine 0.01–0.02 mg/kg IV or IM (or 0.02–0.03 mg/kg) provides good somatic analgesia with minimal cardiovascular depression and is a reasonable choice in a renally compromised patient. Alternatively, hydromorphone 0.05–0.1 mg/kg IV provides more profound analgesia but causes more respiratory depression and is less desirable in a geriatric patient-use lower end of the range if chosen. Methadone is not stocked.
Intraoperative. Fentanyl CRI (2–5 mcg/kg/h, titrated) provides analgesia that is easy to titrate and does not depend on renal clearance. Avoid meperidine (normeperidine accumulation).
Postoperative. Continue buprenorphine q6–8h as needed, or transition to oral tramadol. Tramadol caution: it is metabolized hepatically but its metabolites are renally excreted, and in CKD the dose interval should be extended (e.g., 2–4 mg/kg q8–12h rather than q6–8h) and the patient monitored for sedation and dysphoria. Gabapentin is renally cleared-reduce the dose (e.g., 5–10 mg/kg q12h rather than q8h) and titrate to effect for chronic stiffness.
Anesthetic considerations. Avoid hypotension; maintain mean arterial pressure above 60 mmHg with fluid therapy and vasopressors as needed. Avoid nephrotoxic drugs (aminoglycosides) and drugs requiring renal clearance where possible. Monitor urine output. Recheck renal values 24–48 h postoperatively.